Immatics Stock (NASDAQ: IMTX) stock price, news, charts, stock research, profile.
Open | $10.010 |
Close | - |
Volume / Avg. | 111.269K / 436.524K |
Day Range | 9.670 - 10.036 |
52 Wk Range | 6.460 - 13.160 |
Market Cap | $1.073B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 10.94% |
Days to Cover | 12.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immatics (NASDAQ: IMTX) through any online brokerage.
Other companies in Immatics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Sage Therapeutics (NASDAQ:SAGE).
The latest price target for Immatics (NASDAQ: IMTX) was reported by Cantor Fitzgerald on Thursday, November 2, 2023. The analyst firm set a price target for 0.00 expecting IMTX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Immatics (NASDAQ: IMTX) is $10.42 last updated April 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Immatics.
Immatics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Immatics.
Immatics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.